Federated Hermes’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$88M Buy
156,675
+16,393
+12% +$10.5M 0.14% 162
2025
Q4
$94.9M Buy
140,282
+31,417
+29% +$21.4M 0.16% 155
2025
Q3
$69.6M Buy
108,865
+79,421
+270% +$48.2M 0.12% 201
2025
Q2
$15.8M Sell
29,444
-2,313
-7% -$1.11M 0.03% 477
2025
Q1
$13.3M Sell
31,757
-26,222
-45% -$11.4M 0.03% 491
2024
Q4
$24M Buy
57,979
+1,725
+3% +$757K 0.05% 378
2024
Q3
$28.4M Sell
56,254
-28,387
-34% -$13.8M 0.06% 352
2024
Q2
$41.2M Sell
84,641
-21,320
-20% -$10.7M 0.1% 250
2024
Q1
$57.2M Sell
105,961
-12,840
-11% -$7.02M 0.13% 198
2023
Q4
$65.9M Sell
118,801
-22,211
-16% -$10.4M 0.16% 161
2023
Q3
$61.7M Buy
141,012
+3,338
+2% +$1.66M 0.16% 160
2023
Q2
$69.1M Buy
137,674
+13,547
+11% +$6.49M 0.17% 141
2023
Q1
$62.1M Buy
124,127
+5,068
+4% +$2.43M 0.16% 155
2022
Q4
$48.6M Sell
119,059
-27,925
-19% -$10.8M 0.13% 190
2022
Q3
$47.9M Sell
146,984
-5,771
-4% -$2.12M 0.14% 192
2022
Q2
$53.6M Sell
152,755
-24,608
-14% -$10M 0.15% 189
2022
Q1
$97M Sell
177,363
-44,941
-20% -$23.6M 0.22% 123
2021
Q4
$146M Sell
222,304
-1,122
-0.5% -$704K 0.27% 94
2021
Q3
$139M Sell
223,426
-55,706
-20% -$37.4M 0.26% 98
2021
Q2
$176M Sell
279,132
-17,094
-6% -$9.44M 0.33% 72
2021
Q1
$145M Sell
296,226
-23,563
-7% -$11.8M 0.28% 79
2020
Q4
$160M Buy
319,789
+1,741
+0.5% +$779K 0.33% 72
2020
Q3
$125M Buy
318,048
+1,922
+0.6% +$711K 0.29% 76
2020
Q2
$104M Buy
316,126
+22,775
+8% +$6.59M 0.26% 92
2020
Q1
$71.1M Sell
293,351
-97,066
-25% -$25.3M 0.21% 109
2019
Q4
$102M Sell
390,417
-49,089
-11% -$12.9M 0.23% 95
2019
Q3
$120M Sell
439,506
-104,960
-19% -$29.2M 0.29% 73
2019
Q2
$150M Buy
544,466
+90,849
+20% +$22.4M 0.36% 53
2019
Q1
$101M Buy
453,617
+37,343
+9% +$7.71M 0.25% 82
2018
Q4
$77.4M Sell
416,274
-172,159
-29% -$35.3M 0.21% 99
2018
Q3
$147M Buy
588,433
+85,257
+17% +$20.7M 0.34% 61
2018
Q2
$110M Sell
503,176
-70,953
-12% -$14.6M 0.32% 70
2018
Q1
$110M Sell
574,129
-100,562
-15% -$18.6M 0.32% 65
2017
Q4
$106M Sell
674,691
-13,751
-2% -$2.16M 0.3% 65
2017
Q3
$107M Sell
688,442
-19,512
-3% -$3.08M 0.31% 62
2017
Q2
$114M Buy
707,954
+49,124
+7% +$7.98M 0.33% 55
2017
Q1
$102M Sell
658,830
-322,705
-33% -$44.5M 0.29% 60
2016
Q4
$115M Sell
981,535
-403,637
-29% -$46.1M 0.35% 48
2016
Q3
$156M Buy
1,385,172
+121,287
+10% +$12.8M 0.45% 41
2016
Q2
$117M Sell
1,263,885
-66,006
-5% -$5.67M 0.34% 55
2016
Q1
$104M Sell
1,329,891
-71,535
-5% -$5.15M 0.32% 63
2015
Q4
$102M Sell
1,401,426
-3,595
-0.3% -$256K 0.32% 62
2015
Q3
$104M Buy
1,405,021
+457,912
+48% +$32.8M 0.34% 61
2015
Q2
$60.7M Buy
947,109
+5,113
+0.5% +$354K 0.18% 113
2015
Q1
$72.8M Buy
941,996
+3,016
+0.3% +$235K 0.22% 95
2014
Q4
$69.6M Buy
938,980
+196,142
+26% +$13.8M 0.22% 92
2014
Q3
$43.8M Buy
742,838
+679,114
+1,066% +$42.9M 0.14% 139
2014
Q2
$4.26M Sell
63,724
-2,140
-3% -$136K 0.01% 694
2014
Q1
$4M Sell
65,864
-1,256
-2% -$74.8K 0.01% 700
2013
Q4
$3.57M Buy
67,120
+7,536
+13% +$397K 0.01% 719
2013
Q3
$2.97M Sell
59,584
-9,480
-14% -$456K 0.01% 771
2013
Q2
$3.1M Buy
+69,064
New +$3.02M 0.01% 729

Other funds holding IDXX

Federated Hermes's IDXX Position: Q1 2026 in Review

Federated Hermes increased its Idexx Laboratories (IDXX) stake by 12% in Q1 2026, buying an estimated $10.5M and bringing the position to 156,675 shares worth $88M. The position accounts for 0.14% of the portfolio, ranked #162.

Federated Hermes first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $176M in Q2 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Federated Hermes held 156,675 shares of Idexx Laboratories worth $88M as of Q1 2026.
  • Federated Hermes bought 16,393 Idexx Laboratories shares in Q1 2026, an estimated $10.5M.
  • Idexx Laboratories made up 0.14% of Federated Hermes's portfolio in Q1 2026, its #162 holding.
  • Federated Hermes first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
  • Federated Hermes's Idexx Laboratories position peaked at $176M in Q2 2021.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.